BURLINGTON, Mass., July 25, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) has changed the date of Analyst Day to Tuesday, September 25, 2012 at Ruth's Chris Steakhouse, 148 W 51st Street, New York, NY. It will begin at 9:30 am EDT and conclude at 12:30pm EDT. The Company's senior management will update the investment community on the Company, its growth initiatives and strategic priorities. Please contact Brian Kickham (firstname.lastname@example.org) for more information regarding Analyst Day.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart, including the Over-the-Wire LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt and The UnBalloon.
Our principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803. Additional information can be found at http://www.lemaitre.com.
The LeMaitre Vascular, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10015
CONTACT: LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc.